Solara Active Pharma Sciences Limited — Important, 15-05-2026: Updates

Solara Active Pharma Sciences received ₹129.94 Cr from the Second & Final Call on Rights Equity Shares. The board approved converting 1.15 Cr partly paid shares to fully paid, bolstering the company's equity base.